(EXENS) EXOSENS PROM - Ratings and Ratios
Sensors, Cameras, Modules, Detectors
Description: EXENS EXOSENS PROM
EXOSENS is a French company operating in the Electrical Equipment & Parts industry, with a market capitalization of approximately €2.1 billion. The stock has demonstrated significant price appreciation over the past year, with a 52-week high of €45.25 and a low of €17.05, indicating substantial volatility.
To evaluate the investment potential of EXOSENS, we need to examine key performance indicators (KPIs) such as the Price-to-Earnings (P/E) ratio, which stands at 33.66, and the Forward P/E, which is 24.51. These metrics suggest that the stock may be relatively expensive compared to its earnings, but expectations of future growth could be driving the valuation. The Return on Equity (RoE) of 14.60% indicates a decent level of profitability.
The electrical equipment and parts industry is subject to various economic drivers, including global demand for renewable energy technologies, electrification of transportation, and industrial automation. EXOSENSs performance is likely influenced by these trends, and its ability to capitalize on them will be crucial to its future success. Key economic indicators to watch include global GDP growth, industrial production indices, and trends in the automotive and energy sectors.
From a technical analysis perspective, the stocks recent price movement has been relatively stable, with a current price close to its 20-day Simple Moving Average (SMA). The 50-day SMA is slightly higher, indicating a potential resistance level. The 200-day SMA is significantly lower, suggesting a long-term uptrend. The Average True Range (ATR) indicates moderate volatility, and the average trading volume is around 84,000 shares per day.
To further assess the investment opportunity, it is essential to analyze EXOSENSs financial statements, particularly the income statement, to understand the drivers of its Income Tax Expense and overall profitability. A detailed examination of the companys revenue growth, margin trends, and cash flow generation will provide valuable insights into its financial health and potential for future growth.
EXENS Stock Overview
| Market Cap in USD | 2,847m |
| Industry | Electrical Equipment & Parts |
| IPO / Inception |
EXENS Stock Ratings
| Growth Rating | 94.1% |
| Fundamental | 79.2% |
| Dividend Rating | 11.0% |
| Return 12m vs S&P 500 | 95.4% |
| Analyst Rating | - |
EXENS Dividends
| Dividend Yield 12m | 0.21% |
| Yield on Cost 5y | 0.45% |
| Annual Growth 5y | % |
| Payout Consistency | 100.0% |
| Payout Ratio | 8.1% |
EXENS Growth Ratios
| Growth Correlation 3m | 72.5% |
| Growth Correlation 12m | 91.7% |
| Growth Correlation 5y | 83% |
| CAGR 5y | 71.67% |
| CAGR/Max DD 3y (Calmar Ratio) | 2.86 |
| CAGR/Mean DD 3y (Pain Ratio) | 8.43 |
| Sharpe Ratio 12m | 1.70 |
| Alpha | 129.47 |
| Beta | |
| Volatility | 49.88% |
| Current Volume | 80.9k |
| Average Volume 20d | 136.7k |
| Stop Loss | 44.8 (-6%) |
| Signal | 0.18 |
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (58.6m TTM) > 0 and > 6% of Revenue (6% = 42.3m TTM) |
| FCFTA 0.09 (>2.0%) and ΔFCFTA 5.33pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 26.80% (prev 24.72%; Δ 2.08pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.15 (>3.0%) and CFO 130.5m > Net Income 58.6m (YES >=105%, WARN >=100%) |
| Net Debt (178.7m) to EBITDA (144.6m) ratio: 1.24 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.51 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (50.8m) change vs 12m ago 67.12% (target <= -2.0% for YES) |
| Gross Margin 43.14% (prev 44.54%; Δ -1.40pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 92.57% (prev 50.92%; Δ 41.65pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.31 (EBITDA TTM 144.6m / Interest Expense TTM 34.7m) >= 6 (WARN >= 3) |
Altman Z'' 2.95
| (A) 0.22 = (Total Current Assets 313.8m - Total Current Liabilities 124.8m) / Total Assets 867.3m |
| (B) 0.09 = Retained Earnings (Balance) 79.7m / Total Assets 867.3m |
| (C) 0.15 = EBIT TTM 114.9m / Avg Total Assets 761.9m |
| (D) 0.20 = Book Value of Equity 87.0m / Total Liabilities 437.8m |
| Total Rating: 2.95 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 79.21
| 1. Piotroski 6.50pt = 1.50 |
| 2. FCF Yield 3.09% = 1.54 |
| 3. FCF Margin 11.47% = 2.87 |
| 4. Debt/Equity 0.63 = 2.31 |
| 5. Debt/Ebitda 1.24 = 1.41 |
| 6. ROIC - WACC (= 19.44)% = 12.50 |
| 7. RoE 14.60% = 1.22 |
| 8. Rev. Trend 78.19% = 5.86 |
| 10. EPS Trend data missing |
What is the price of EXENS shares?
Over the past week, the price has changed by -3.35%, over one month by +9.16%, over three months by +17.65% and over the past year by +127.44%.
Is EXOSENS PROM a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EXENS is around 53.96 EUR . This means that EXENS is currently undervalued and has a potential upside of +13.24% (Margin of Safety).
Is EXENS a buy, sell or hold?
What are the forecasts/targets for the EXENS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 47.6 | -0.2% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 58.4 | 22.5% |
EXENS Fundamental Data Overview
Market Cap EUR = 2.44b (2.44b EUR * 1.0 EUR.EUR)
P/E Trailing = 36.0569
P/E Forward = 22.6244
P/S = 5.6559
P/B = 5.1589
Beta = None
Revenue TTM = 705.3m EUR
EBIT TTM = 114.9m EUR
EBITDA TTM = 144.6m EUR
Long Term Debt = 247.5m EUR (from longTermDebt, last quarter)
Short Term Debt = 5.09m EUR (from shortTermDebt, last quarter)
Debt = 268.4m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 178.7m EUR (from netDebt column, last quarter)
Enterprise Value = 2.62b EUR (2.44b + Debt 268.4m - CCE 89.8m)
Interest Coverage Ratio = 3.31 (Ebit TTM 114.9m / Interest Expense TTM 34.7m)
FCF Yield = 3.09% (FCF TTM 80.9m / Enterprise Value 2.62b)
FCF Margin = 11.47% (FCF TTM 80.9m / Revenue TTM 705.3m)
Net Margin = 8.31% (Net Income TTM 58.6m / Revenue TTM 705.3m)
Gross Margin = 43.14% ((Revenue TTM 705.3m - Cost of Revenue TTM 401.1m) / Revenue TTM)
Gross Margin QoQ = 61.96% (prev 22.70%)
Tobins Q-Ratio = 3.02 (Enterprise Value 2.62b / Total Assets 867.3m)
Interest Expense / Debt = 2.55% (Interest Expense 6.84m / Debt 268.4m)
Taxrate = 27.30% (10.5m / 38.4m)
NOPAT = 83.5m (EBIT 114.9m * (1 - 27.30%))
Current Ratio = 2.51 (Total Current Assets 313.8m / Total Current Liabilities 124.8m)
Debt / Equity = 0.63 (Debt 268.4m / totalStockholderEquity, last quarter 429.5m)
Debt / EBITDA = 1.24 (Net Debt 178.7m / EBITDA 144.6m)
Debt / FCF = 2.21 (Net Debt 178.7m / FCF TTM 80.9m)
Total Stockholder Equity = 401.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.76% (Net Income 58.6m / Total Assets 867.3m)
RoE = 14.60% (Net Income TTM 58.6m / Total Stockholder Equity 401.5m)
RoCE = 17.70% (EBIT 114.9m / Capital Employed (Equity 401.5m + L.T.Debt 247.5m))
RoIC = 24.59% (NOPAT 83.5m / Invested Capital 339.7m)
WACC = 5.15% (E(2.44b)/V(2.71b) * Re(5.51%) + D(268.4m)/V(2.71b) * Rd(2.55%) * (1-Tc(0.27)))
Discount Rate = 5.51% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 29.27%
[DCF Debug] Terminal Value 74.73% ; FCFE base≈59.1m ; Y1≈47.7m ; Y5≈32.9m
Fair Price DCF = 12.02 (DCF Value 610.3m / Shares Outstanding 50.8m; 5y FCF grow -23.14% → 3.0% )
Revenue Correlation: 78.19 | Revenue CAGR: 55.11% | SUE: N/A | # QB: 0